From US FDA
Glenmark Pharmaceuticals announced that Glenmark Generics Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for the oral contraceptive Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.09 mg/0.02 mg, the therapeutic equivalent of Lybrel of Wyeth Pharmaceuticals, Inc. (which is no longer being marketed in the United States).Powered by Capital Market - Live News
